On June 11, the 2025 Beijing CBD Forum Annual Conference commenced, held concurrently with the United Nations Development Programme (UNDP) Asia Mayors Forum. The conference will run until June 13.
Beijing CBD is the city’s “golden business card” and a vital gateway for the capital’s global engagement. During the forum, over 6,000 representatives from politics, business, and academia worldwide gathered in Beijing to explore international economic and trade cooperation. The opening ceremony, alongside the 2025 Beijing CBD Multinational Corporation Summit, the Beijing CBD Global Board Meeting, and four other flagship international events, as well as numerous parallel forums, were held simultaneously.
70% of Speakers Are International Guests, Representing Over 40 Countries and Regions
On the morning of June 11, the China World Hotel was filled with distinguished guests. Over 20 representatives from Asian cities, 30 delegates from international organizations and business associations, and more than 6,000 participants from the Global Alliance for Innovation in Business Districts and the China Business District Alliance attended the forum. Statistics show that 70% of the main forum speakers were international guests, with attendees hailing from over 40 countries and regions and spanning more than 10 core industries, sparking in-depth discussions across specialized fields. This diverse international participation infused the forum with global perspectives and cutting-edge ideas.
Centered on the permanent theme of “Dialogue with the World for Common Development,” the forum featured one opening ceremony (including the 2025 Beijing CBD Multinational Corporation Summit), four flagship international events, and multiple parallel forums.
During the opening ceremony’s achievements release session, Chaoyang District unveiled several high-quality development projects and outcomes. International business associations and global business district representatives jointly launched the “Building a Clean, Beautiful, and Sustainable World Together” initiative. Additionally, the “Belt and Road” Express Service Platform’s “CBD Lounge” was inaugurated. The forum also recognized the second batch of standing council members of the Beijing CBD Multinational Corporation Summit, establishing a new benchmark for foreign-funded enterprises based on headquarters prioritization and industry leadership.
Beijing CBD ranks as China’s top and the world’s seventh-largest business district. In 2024 alone, the CBD area added 10 new regional headquarters of multinational corporations, bringing the total to 122. Since 2000, the Beijing CBD Forum has evolved into a frontline platform for China’s global dialogue and a robust pillar for Beijing’s role as an international exchange hub.
UNDP Asia Mayors Forum Held Concurrently, Four Flagship Events to Boost Economic Cooperation
Beijing CBD is the most concentrated area for foreign-funded enterprises in the capital. The forum aims to foster international economic collaboration and attract investment. During the event, Beijing CBD will host four flagship international activities: the Beijing CBD Global Board Meeting Series, Government-Business Dialogue, Global Business Districts “Experience Beijing” Event, and Sino-Foreign Automakers Roundtable.
On June 12, the Beijing Municipal Commerce Bureau and the CBD Administrative Committee will co-host a policy-focused government-business dialogue on stabilizing foreign investment. The session will interpret the latest policies, address corporate needs, and facilitate exchanges to support foreign enterprises in China.
Held concurrently, the UNDP Asia Mayors Forum, themed “Collaborative Innovation: Co-Creating Low-Carbon and Sustainable Future Cities,” brings together global urban leaders, multinational executives, international organization representatives, and academic experts. Guided by the UN Sustainable Development Goals (SDGs), the forum emphasizes international cooperation, multi-stakeholder collaboration, and financial and technological innovation to drive urban sustainability.
Beijing is accelerating its development as a global green economy leader. As a high-density economic hub, the CBD plays a critical role in energy conservation, renewable energy adoption, and efficiency improvements.
In recent years, Beijing CBD has implemented policies like the “Measures to Promote High-Quality Development of Beijing CBD” and the “CBD Building Quality Grading Standards” to support green industries and enhance smart, eco-friendly services. Currently, LEED Gold or higher-certified buildings in the area span 4.9 million square meters.
Beijing CBD Elected Chair of Global Alliance for Innovation in Business Districts
Today, Beijing CBD stands among the world’s premier business districts, alongside Manhattan, La Défense, and Hong Kong’s Central. Hosting nearly 16,000 foreign entities, it is Beijing’s most concentrated area for multinational regional headquarters. The CBD Administrative Committee continues to refine its business-friendly environment.
Initiatives like the “CBD Investment Service Center” streamline administrative processes, while the “Headquarters Growth Plan” assists companies like BMW China and Toyota Financial Services in obtaining regional headquarters status. In May 2025, the “Beijing CBD Foreign Investment Service Center” launched, positioning itself as the “first stop for foreign enterprises entering China.”
Through institutional innovation, Beijing CBD advances the integrated business environment of the Beijing-Tianjin-Hebei region. In June 2023, the “Beijing CBD-Tianjin Port Collaborative Service Center” was established with Tianjin Port Group and Beijing Customs, offering one-stop logistics services.
Aligned with global trade standards, Beijing CBD is building a market-oriented, law-based, and internationalized business ecosystem. It has attracted top arbitration bodies like the Beijing Arbitration Commission and the Singapore International Arbitration Centre.
In 2024, Beijing CBD was elected chair of the Global Alliance for Innovation in Business Districts, enhancing Beijing’s global influence. This year, multinationals like Aramco Asia and Hamamatsu Photonics have chosen the CBD for their global board meetings.
Chaoyang to Issue Consumption Vouchers, CBD Pop-Up Walkway Opens
Beijing CBD, home to landmarks like China World Mall, SKP, and Xiushui Street, is evolving into a trillion-yuan international commercial hub. During the forum, attendees and visitors can enjoy discounts across CBD’s retail spaces.
From June 13–15 (Friday–Sunday), a CBD Pop-Up Walkway will open at China World Summit Wing from 11 AM to 9 PM, featuring specialty products like Canadian ice wine, Thai cuisine, and Belgian skincare, alongside camping zones and stamp-collecting activities.
Chaoyang District will distribute ¥3.5 million in consumption vouchers for retail, supermarkets, F&B, and cultural-sports sectors.
The 2025 Beijing CBD Forum will host 50+ annual events, including a Hot Dog Festival, Coffee Festival, Beijing Spicy Festival, and Xiushui Street Fashion Show. Details are available on the official WeChat account “Beijing CBD Window.”
HONG KONG, Jun 13, 2025 - (ACN Newswire via SeaPRwire.com) - Tat Hong Equipment Service Co., Ltd. (“Tat Hong” or the “Company”, together with its subsidiaries, the “Group”) (Stock Code: 2153), the first foreign-owned tower crane service provider established in the PRC, has announced its annual results for the year ended 31 March 2025 (“FY2025” or the “Year”).In FY2025, the Group recorded revenue of approximately RMB 634.6 million (2024: RMB682.3 million). Loss attributable to equity holders of the Company for the year ended 31 March 2025 amounted to RMB 120.5 million (2024: RMB95.6 million). The increase in loss was primarily due to (i) slower economic growth and a downturn in the construction industry led to a decline in revenue; and (ii) the adjustment of deferred tax resulted in increased income tax expenses.As at 31 March 2025, the Group is managing a total of 1,180 tower cranes. The Group’s total tonne metres (TM) in use decreased from 3,178,404 for the year ended 31 March 2024 to 3,137,910 for the year ended 31 March 2025. As at 31 March 2025, the Group had 256 projects in progress with a total outstanding contract value of approximately RMB 721.4 million and 38 projects on hand of total expected contract value at approximately RMB 78.7 million.During the financial year, under the effect of insufficient market demand and the decline in the average monthly service price of tower cranes per TM, the supply and demand mismatch had resulted in high market competition in the entire construction machinery industry. To cope with the sluggish market conditions, the Group has developed tailored strategies and continuously adjusted its business mix, progressively reducing the revenue contribution from the real estate sector.In response to the national initiative to vigorously develop clean energy and aligning with market trends and growth potential, the Group has concentrated on thermal power projects and nuclear power projects. Clean energy projects usually entail lengthy construction cycles and large-scale operations, and the Group has obtained significant advantages by leveraging its extensive industry experience, established construction expertise, and strong technical capabilities.In FY2025, the Group accelerated its overseas market presence, thoroughly implemented its operational strategies through its subsidiaries in the Greater Bay Area and in Indonesia, and gradually expanded its fleet of large and medium-sized tower cranes. Up to now, large-tonnage-meter tower cranes have been predominantly deployed in the projects across Hong Kong and Indonesia. In light of the above, clean energy and overseas projects remain the Group’s key priorities for future development.During the year, the Group had continued the investment in the digitalization of the management platform and the research and development of new tower crane technical solutions. As at 31 March 2025, the Group possess 187 registered patents for utility models and inventions relating to tower cranes. The robust technical capabilities will continue to enable the Group to procure projects, and the enhancement in the research and development capabilities for tower crane technical solutions will reinforce the excellent delivery in services.Mr. Sean Yau, CEO of Tat Hong Equipment Service Co., Ltd., said: " In addition to the downturn in the property market and the construction industry, the geopolitical tensions and the depreciation pressure on the RMB further weakened the economy of the PRC. Tackling these economic challenges and the changing business environment., we have promptly adopted adjustments to our development strategies, including the expansion to the clean energy construction segment and the geographical expansion to the Greater Bay Area and Indonesia, and we believe the positive impact will be reflected in the coming years.Mr. Roland Ng, Chairman of Tat Hong Equipment Service Co., Ltd., said: “In the most trying circumstances, we remain steadfast in our original mission. Guided by our core corporate values ‘Virtue , Safety and Excellence , we will continue to excel in our business endeavors. In the coming financial year, we will continue to further strength our position in the above new segments and locations, and seize new opportunities in the market, so as to concentrate on the research and development of new tower crane technologies to equip ourselves with the most robust technical capabilities to deliver excellent services to our clients. Furthermore, we will also continue to achieve resources sharing, cost reduction and efficiency enhancement. With all the above measures, we believe we can fulfil the Group’s goal to become ‘the best construction equipment service provider’ in the industry.”About Tat Hong Equipment Service Co., Ltd. (Stock Code: 2153)Tat Hong Equipment Service Co., Ltd. is the first foreign-owned tower crane service provider established in the PRC. Since 2007, the Group has established as a tower crane service provider for one-stop tower crane solution services from consultation, technical design, commissioning, construction to after-sales services primarily to Chinese Special-tier and Tier-1 EPC contractors. Guided by its core values, “Virtue, Safety and Excellence”, the Group has successfully established its market position and maintained stable, reputable and loyal customer base in the construction industry in the PRC.Media EnquiriesStrategic Financial Relations LimitedHeidi SoTel:(852) 2864 4826Email: heidi.so@sprg.com.hk Mel LaiTel:(852) 2864 4855Email: mel.lai@sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.
HONG KONG, Jun 13, 2025 - (ACN Newswire via SeaPRwire.com) - With the national strategy of “new quality productive forces” driving high-quality development, Yee Hop Holdings Limited (“Yee Hop Holdings”; stock code: 1662.HK) subsidiary Absolute Pure EnviroSci Limited (“APEL” or “the Company”) is actively aligning with national policies. It has recently established a Microfactory in collaboration with the Hong Kong Productivity Council (“HKPC”) to industrialize the patented Wisepura Aquapura porous silica capsule technology in Hong Kong, promoting smart manufacturing and new industrialization. The HKPC’s Life & Health Tech Hall, which opened in March this year, showcases over 20 research achievements and innovative applications developed by the HKPC, InnoHK, local universities, and industry partners, including the patented Wisepura Aquapura porous silica capsule technology.The World’s First Wisepura Aquapura Microfactory Fully OperationalAs a significant achievement of the collaboration, the world’s first Wisepura Aquapura Microfactory, developed in collaboration between APEL and HKPC, was officially launched on 13 June 2025 in Kowloon Bay, Hong Kong. This marks the successful implementation of the first phase of “Industry 4.0” and a significant milestone in the industrialization of APEL’s research achievements. During the inauguration ceremony, attended by numerous guests from the investment and business sectors, Mr. Jackin Jim, Chairman of Yee Hop Holdings, Dr. David Chung, Chairman of APEL, and Dr. Pat Yeung, Director of APEL, jointly unveiled the Microfactory, officially announcing its commencement of operations.Dr. Pat Yeung, Director of APEL (first from the left), Mr. Jackin Jim, Chairman of Yee Hop Holdings (second from the left), Mr. Mohamed Butt, Executive Director of HKPC (second from the right), and Dr. David Chung, Chairman of APEL (first from the right) are pictured together at the Wisepura Aquapura Microfactory Inauguration Ceremony.Dr. David Chung, Chairman of APEL, said, “We are honored to collaborate with HKPC in establishing the Wisepura Aquapura Microfactory, and we would like to extend our heartfelt gratitude to HKPC for their support. This collaboration highlights our strong research and innovation capabilities in the field of life and health technology. The official commencement of production at the APEL Wisepura Aquapura Microfactory enhances our ability to meet the growing market demand and injects new momentum into the company’s development. Looking ahead, we will continue to expand our network of partners and actively pursue international opportunities, endeavoring to bring local research achievements to the global stage and contribute to global health and environmental protection, working together for a sustainable future.”Dr. David Chung, Chairman of APEL, delivers a speech at the inauguration ceremony.Establishes Strategic Partnership with Shanhu Group to Explore New Opportunities in Water Purification and Aquaculture Technology in the Greater Bay AreaGuangdong Shanhu Group Co., Ltd. (“Shanhu Group”), a global leader in indoor air environment solutions, has seen its core product, industrial fans, gain widespread popularity across six continents, serving over 50 million users. Since 2015, Shanhu Mechanical and Engineering Co., Ltd., a subsidiary of Shanhu Group, has taken a forward-looking approach in the research and development (R&D) of intelligent and energy-saving technologies for aquaculture machinery. On 13 June 2025, APEL officially signed a strategic Memorandum of Understanding (MoU) with Shanhu Group to jointly enter the water purification and intelligent aquaculture sectors. The collaboration aims to develop advanced solutions for high-demand applications such as water purification equipment, ecological restoration technologies, and smart monitoring systems. These innovations will target environmental projects including river remediation, black and odorous water treatment, and ecosystem rehabilitation. Additionally, the partnership will address the stable demand for new filtration materials, water treatment processes, and water quality monitoring technologies in municipal wastewater treatment plants and industrial park facilities. The two companies will also establish cooperative relationships with government environmental agencies and municipal engineering firms to participate in wastewater treatment project bids and provide customized solutions.The collaboration encompasses technological R&D, market expansion, and resource sharing. The two parties will jointly develop intelligent water quality monitoring systems, leveraging big data and artificial intelligence (AI) to optimize aquaculture decision-making while promoting high-efficiency purification technologies for environmental engineering and municipal wastewater treatment markets. The project will integrate Shanhu Group's expertise in electromechanical equipment and disinfection technologies with APEL's proprietary Wisepura Aquapura Microfactory water treatment solutions. This one-year agreement, renewable upon expiration, will initially focus on deploying the collaborative achievements in the Guangdong-Hong Kong-Macao Greater Bay Area through business and technical exchange forums. The partnership is expected to drive the advancement of environmental protection and aquaculture industries in the region, fostering industrial chain transformation. Looking ahead, the collaboration aims to gradually expand into overseas markets.APEL (left) and Shanhu Group sign a strategic Memorandum of Understanding.Advancing towards a new era of “Industry 4.0” with smart manufacturingIn advancing “Industry 4.0” initiative, the APEL Wisepura Aquapura Microfactory integrates cutting-edge technologies such as physical AI, the Internet of Things, and big data into its manufacturing processes. This enables smart monitoring and automated management, enhancing overall operational efficiency and product quality. To mitigate the impact of rapid temperature increase during mixing on the structural integrity and performance of the smart silica capsules, the factory has installed a customized smart temperature control system powered by physical AI to ensure stable product quality. The factory is also equipped with a human-machine interface (HMI), programmable logic controllers (PLCs), and clean-in-place (CIP) systems to boost production efficiency and flexibility. Additionally, it features an Industrial Internet of Things (IIoT) monitoring system to track change of temperature and volume and electricity usage in real time, optimizing energy management. It also adopts just-in-time (JIT) production management to reduce inventory backlog and resource waste, comprehensively promoting efficient smart manufacturing operations.By implementing lean management and the principles of smart manufacturing, APEL’s world-first Wisepura Aquapura Microfactory successfully integrates customized production technology, mechanical automation, and data visualization within a limited space. This achievement enables flexible small-batch customized production and achievies “Industry 4.0 1i Maturity,” paving the way for physical AI applications.Guests visiting the APEL Wisepura Aquapura Microfactory.Dual Advancement in Health and Environmental Technology InnovationWater is an essential resource for sustaining human life and ecological health. However, urban development has exacerbated water pollution, posing significant threats to public health and ecosystems. To address these challenges, APEL has developed Wisepura Aquapura, featuring the world’s first patented porous silica capsule technology. This innovation has received gold and silver medals at the International Exhibition of Inventions of Geneva in 2022 and 2024, respectively. It intelligently releases active ingredients upon contact with water, effectively eliminating over 95% of harmful microorganisms and antibiotic-resistant bacteria while also meeting diverse application needs. This technology has been widely applied across Hong Kong’s public infrastructure, targeting over 30 types of bacteria, fungi, and viruses in water supply, air conditioning, and sewage systems—including Legionella, hand-foot-and-mouth disease pathogens, influenza virus, and Candida albicans—significantly reducing the risk of waterborne and aerosol-transmitted diseases. Moreover, the silica capsule can be reused multiple times and safely disposed of at the end of its lifecycle, thereby minimizing environmental impact and setting a new standard for water treatment solutions.APEL’s world-first Wisepura Aquapura Microfactory successfully integrates customized production technology, mechanical automation, and data visualization, achieving “Industry 4.0 1i Maturity.”About Wisepura Aquapura MicrofactoryLocated in Kowloon Bay, the APEL Wisepura Aquapura Microfactory scales up laboratory processes to pilot production while effectively adapting to the spatial constraints of traditional multi-story industrial buildings in Hong Kong. It achieves a high production capacity of 6 tons per day. At the heart of the production line is its C-shaped layout, laying a solid foundation for efficient operations. The factory is equipped with mixing, filling, and screw capping systems, along with smart technologies, and a customized pipeline system that connects 5 pharmaceutical-grade mixing tanks, enabling comprehensive lean management. Due to the limited space, the factory is equipped with a 2.5-meter-high automatic capping machine that maximizes vertical space, demonstrating the perfect integration of space efficiency and smart technology.The launch of the Microfactory not only significantly enhances production efficiency but also accelerates APEL’s collaboration with Superpower Pumping Engineering Co., Ltd., facilitating the market expansion of research products. Furthermore, the Microfactory has received official orders from the Drainage Services Department, demonstrating strong recognition of its solutions and generating tangible economic benefits for the Company. To tap into the Japanese market, which places high value on personal health and environmental hygiene, APEL is currently holding an innovative interactive exhibition at The Lab. in Osaka to showcase its three flagship products—Wisepura water and air purification systems, GERMAGIC™ antimicrobial coating, and GERMAGIC™ PET health care solutions for pets—seizing growth opportunities in Asia’s health technology industry.About Yee Hop Holdings LimitedYee Hop Holdings Limited (stock code: 1662.HK) is a company listed on the Main Board of the Stock Exchange of Hong Kong Limited and a long established contractor in Hong Kong, principally engaged in the provision of foundation works and tunneling works. In addition, its associate company, Windmill Street Development, is engaged in the development of premium property projects in Birmingham, the United Kingdom. In 2023, the Group established Absolute Pure EnviroSci Limited (“APEL”), which focuses on health and environmental innovations, including the distribution and research and development of specialty biochemical and biomedical products. APEL has also established laboratories in collaboration with The Hong Kong University of Science and Technology (“HKUST”) and the Hong Kong Science Park successively. The joint laboratory, “HKUST-AP EnviroSci Ltd. Joint Laboratory on Health and Environmental Innovation,” was officially launched on 10 January 2024. Additionally, the “APEL Biomedical Technology Innovation and Translational Commercial Laboratory” located at the Hong Kong Science Park was officially inaugurated on 13 March 2024.For more information about Yee Hop Holdings, please visit: http://www.yee-hop.com.hk/About Absolute Pure EnviroSci LimitedAbsolute Pure EnviroSci Limited (“APEL”), is an indirect non-wholly owned subsidiary of Yee Hop Holdings Limited, a company listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 1662.HK). With a mission to improve the quality of life and living environments, APEL is principally engaged in the research and development and commercialization of health and environmental innovations. Leveraging its Multilevel Antimicrobial Polymer (MAP-1) technology, APEL has developed specialized application formulas in four key areas: air purification in aircraft, water purification, livestock health, and eco-friendly building materials, all designed to address pressing global challenges. APEL looks forward to working with researchers and industry partners worldwide to drive further health and environmental innovations.For more information about APEL, please visit: https://apesl.com/For media inquiries, please contact:AJA (IR & Communications)Avy YuTel: +852 9500 4443Email: avy.yu@ajacapital.com.hk / info@ajacapital.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.
KEY HIGHLIGHTS- Revenue up by 7.4% to HK$1,576.9 million- Profit from continuing operations rose by 43.1% to HK$300.8 million- Net gearing ratio down to 8.3% from 12.2%- Recommended Final Cash Dividend of HK5.50 Cents Per Share and Special Cash Dividend of HK6.00 Cents Per Share- Continued enrichment of pipeline through R&D and strategic in-licensing- Improved operational efficiency by enhancing capacity and optimizing production leverage efficiencyHONG KONG, Jun 13, 2025 - (ACN Newswire via SeaPRwire.com) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing, and sale of essential medicines and specialty drugs, today announced the annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2025 ("FY2025" or the "Reporting Period").Building on the growth momentum of previous years, Jacobson Pharma continued to make promising progress, achieving total revenue of approximately HK$1,576.9 million during the Reporting Period, a year-on-year growth of 7.4%. Profit for the year from continuing operations increased by 43.1% to HK$300.8 million, reflecting the Group’s steadfast commitment to strategic execution and operational excellence.The Group’s financial position remains strong, providing a solid foundation for fuelling future development and dividend returns to shareholders. Bolstered by a robust business performance and persistent cost management, the Group achieved an adjusted EBITDA of HK$572.8 million. Net gearing ratio improved to 8.3% from 12.2% at the close of FY2025, and cash reserves held steady at HK$509.0 million.The Board recommends the payment of a final cash dividend of HK5.50 cents per share (FY2024: HK3.00 cents per share) and a special cash dividend of HK6.00 cents per share (FY2024: Nil). Including the interim cash dividend of HK3.50 cents per share already paid, the total cash dividend for FY2025 would be HK15.00 cents per share (FY2024: HK5.50 cents per share), up by 172.7% year-on-year.Robust Portfolio Meets Rising Healthcare DemandThe Group’s sales growth in FY2025 was driven by multiple factors. Hong Kong’s extended flu season, compounded by circulating respiratory pathogens, led to a significant surge in demand for cold and flu treatments. Broader healthcare trends further supported this momentum, including an aging population, high rates of chronic conditions like diabetes and hypertension, and growing mental health needs. Additionally, public health initiatives heightened awareness of preventive care, reinforcing demand for medications and medical consultations. Together, these trends contributed to sustained sales momentum across the Group's businesses throughout the Reporting Period.The Group remains well-positioned to meet Hong Kong’s growing healthcare needs with its broad portfolio of essential medicines and specialty drugs. Backed by an efficient supply chain, it ensures reliable access to cost-effective treatment choices while reinforcing its role as a trusted healthcare service provider.Sustained R&D Momentum and Specialty Portfolio ExpansionMomentum in expanding the Group’s R&D pipeline of the Group was sustained throughout the Reporting Period, advancing its strategy to broaden the product portfolio. As of 31 March 2025, the pipeline comprised 219 products at various development stages.To expand its specialty drugs portfolio, the Group concluded various in-licensing agreements with global manufacturers for 20 high-performing products across key therapeutic areas such as immunology, oncology, cardiology, neurology, and rare diseases. Selected for their strong clinical profiles and market potential, these additions support sustained growth and reflect the Group’s commitment to advancing patient care through innovative therapies.Bringing Innovation to Enhance Patient OutcomesThe Group continues to expand market reach for Arsenic Trioxide Oral Solution, co-developed with The University of Hong Kong to treat acute promyelocytic leukaemia (APL). Clinical trials show a 97% survival rate and 100% molecular remission, earning it the Orphan Drug Designation from both the U.S. FDA and EMA. A global Phase III trial will be launched in 2026 with market approval targeted for 2028.Jacobson Pharma also achieved a significant milestone on 20 February 2025, with the launch of supply chain liaison services for Axicabtagene Ciloleucel (Yikaida) – a CAR-T therapy - in partnership with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Fosun Kairos Biotechnology Inc.. Supported by an Advanced Therapeutic Product (ATP) logistics license, this breakthrough therapy for diffuse large B-cell lymphoma marks a major advance in next-generation cancer care.Powering Growth with Smart ProductionIn line with the Groups’ strategic goal of enhancing its manufacturing capabilities, Jean Marie Pharmacal Co Limited, a member of the Group, commenced the development of a new pharmaceutical facility at Tai Po InnoPark in February 2025. Supported by the Hong Kong Government’s New Industrialisation Acceleration Scheme, the facility will house 10 smart production lines for sterile eye drops, solid dosage forms, and oral liquids. Leveraging AI, robotics, and real-time analytics, the advanced facility will boost production efficiency and quality standards. Trial production is slated for late 2026, with a focus on developing specialty products to cater to unmet medical needs. This investment strengthens the Group’s industry leadership and supports Hong Kong’s emergence as a hub for advanced pharmaceutical manufacturing.Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, stated, “FY2025 has been another eventful year for Jacobson Pharma, underscoring the strength of our strategy, the dedication of our team, and the trust of our stakeholders. These foundations continue to position us as a leading force in Hong Kong’s generic pharmaceutical sector.Looking to 2026, we remain optimistic about our prospects and growth. Healthcare policy reforms and rising medication demand from an aging population and chronic conditions will fuel the growth of the generic drugs market. With a strong pipeline, expanding partnerships, and digital innovation, we are well-positioned to seize growth opportunities and create sustainable values for the Group’s businesses”About Jacobson Pharma Corporation Limited (Stock Code: 2633)Jacobson Pharma is a leading pharmaceutical company in Hong Kong vertically integrated and engaged in the research, development, production, sale and distribution of essential medicines and specialty drugs. As a major provider of generic drugs in Hong Kong, the Group has one of the most extensive sales and distribution coverage for both the private and public sectors in Hong Kong, with an expanding reach into strategically selected Asian markets. Carrying a broad product portfolio and taking a pre-eminent market position in a number of therapeutic categories, the Group operates a host of 9 PIC/S GMP licensed production facilities for generic drugs in Hong Kong.The Group is committed to strategically enhancing its portfolios by introducing high-value-added specialty products. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan and Cambodia, forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com Copyright 2025 ACN Newswire via SeaPRwire.com.
PIONEERTOWN, CA, June 13, 2025 - (ACN Newswire via SeaPRwire.com) - ESCAPE Records releases two transcendent works from its secretive Mojave Desert hub in Pioneertown CA: the Parallel Universe EP, a genre-defying musical odyssey from touring electronic artists and industry veterans, and Gong Song! (Live from Escape, Pioneertown CA), a 45-minute sound healing masterpiece by Alessandra Montana.Naturally Occurring Emoji - BEEPLEEveryday from BEEPLE. Cover of Parallel Universe EP. Courtesy of Escape Records LLC.Crafted where social media fades to the obscure and creativity thrives, these two new records aim to forge deep audience connections - inspiring a sense of solidarity between the creative and their audience.The Parallel Universe EP blends electronic, Americana, and Latin vibes, born during a songwriting retreat at ESCAPE's legendary studio, some 40 miles from the gates of Coachella in the high desert of California, a mile above sea level under a myriad of stars. Listeners are invited to ponder what their life would be like in a parallel universe; evoking poignant emotions in today's somewhat turbulent world.Tracks are shared by studio founder and producer ROC Gardner, Latin Grammy-nominated Cimafunk (La Vida), Jamie N Commons (Hold Me While You Wait), DJ Tennis (Life and Death), and Grammy-nominated Jan Blomqvist (Remote Control), joined by producers Joseph Ray (Nero), Daniel Cantisani, Nikko Gibler (RicoshÄ“i), and Devlin Thorn alongside artists that include Kim Bullard (Elton John) and Craig McClune (David Gray) who lent their expertise to evolving the tracks.Mixed by Mick Guzauski (Daft Punk, The Weeknd, Michael Jackson) and mastered by Bernie Grundman, tracks include Mezcalita (June 13), Happy Unhappy (June 20), La Sugar (June 27), and Never Know (July 4). BEEPLE's surreal artwork Naturally Occurring Emoji and an AI-driven video by The Dor Brothers amplify the EP's cosmic narrative."The universal sky we spent each night under sparked something raw," says ROC. "It was awesome breaking out of our channels - we got to capture all these ideas, unbound by trends or any other concerns - it was great fun!"Simultaneously, Alessandra Montana's Gong Song! (Live from Escape) captures a live 45-minute sound journey, recorded meticulously with vintage gear and microphones at ESCAPE. Guided by mixing engineer Rob Columbus and mastered by Grundman, Montana's gongs and sacred instruments weave a meditative portal for healing."Escape's magic let me share my practice globally. I can't wait for people to hear this and experience the journey we went on," says Montana.ESCAPE, a 140-acre creative haven hosting Rüfüs Du Sol, Arctic Monkeys, Usher, RAYE - and many others - fosters unfiltered artistry. The studio hopes to deliver magic - and its music - unfettered and unfiltered.Visit www.esca.pe for more.Assets: Press release, artwork, lyrics, .wav files available upon request.Interviews: info@esca.peJan Blomqvist appears courtesy of Armada Music B.V.Tracks:Mezcalita (1st Single): https://audiosalad.ffm.to/commons-roc-mezcalitaParallel Universe EP: https://audiosalad.ffm.to/parallel-universeGong Song! (Live from Escape): https://audiosalad.ffm.to/gong-songContact InformationSteven Bradley9/9 - Digital/Social Mediaescape@9slash9.comEscape RecordsLabel Contactinfo@esca.peSOURCE: Escape Records LLC Copyright 2025 ACN Newswire via SeaPRwire.com.
TOKYO, June 13, 2025 - (JCN Newswire via SeaPRwire.com) - TRENDE Inc., a leading renewable energy solutions provider in Japan, today announced the formation of a strategic capital and business alliance with Tokyu Land Corporation, a leading Japanese real estate developer. This partnership marks a significant milestone in advancing the adoption of distributed renewable energy and peer-to-peer (P2P) electricity trading in Japan’s real estate sector.As part of the extension round of TRENDE’s Series C financing executed on March 19, 2025, Tokyu Land Corporation has joined as a new shareholder. This investment underscores Tokyu Land’s commitment to accelerating the deployment of sustainable energy solutions across its extensive real estate portfolio.Driving Innovation in Real Estate and EnergyUnder the new alliance, TRENDE and Tokyu Land will collaborate on several key initiatives, including:Strategic operation of power generation businesses utilizing residential solar and battery systems to provide enhanced grid flexibility and resilience.Joint development and social implementation of P2P electricity trading platforms that enable property owners and residents to directly transact renewable energy, thereby increasing real estate value and promoting energy self-sufficiency.Leveraging Tokyu Land’s "ReENE" renewable energy brand and real estate expertise with TRENDE’s advanced technology and market-leading P2P platform to deliver innovative, customer-centric energy solutions.Tadatoshi Senoo, President of TRENDE Inc., commented: “This partnership with Tokyu Land Corporation is a pivotal step toward realizing our mission of building a society that actively utilizes renewable energy. By combining our strengths in technology and real estate, we aim to accelerate the expansion of P2P electricity trading and unlock new value for communities and property owners alike."About TRENDE Inc. TRENDE Inc. provides customer-centric renewable energy solutions in Japan through its solar and battery leasing service “Teraris” (https://teraris.jp/) and innovative peer-to-peer (P2P) electricity trading platform. With a mission to accelerate renewable energy adoption and redefine Japan's energy ecosystem, TRENDE is backed by prominent investors including Itochu Corporation, Idemitsu Kosan Co., Ltd., Dubai Electricity and Water Authority (DEWA), Tokyo Century Corporation, National Federation of Agricultural Cooperative Associations (ZEN-NOH), Zen-Noh Energy Corporation, Toshiba Corporation and Tokyu Land Corporation. For more information, visit https://trende.jp/.About Tokyu Land CorporationHeadquartered in Shibuya, Tokyo, Tokyu Land Corporation is a leading real estate developer committed to creating sustainable communities. The company operates the "ReENE" brand for renewable energy initiatives. For more details, visit https://www.tokyu-land.co.jp/ and https://tokyu-reene.com/.Media Contact:TRENDE Inc.Public RelationsEmail: pr@trende.jp Copyright 2025 JCN Newswire via SeaPRwire.com.
